Currently out of the existing stock ratings of Keyur Parekh, 8 are a BUY (72.73%), 3 are a HOLD (27.27%).

Keyur Parekh

Work Performance Price Targets & Ratings Chart

Analyst Keyur Parekh works with a stock forecast success ratio of 33.33% fulfilled within 242.5 days on average.

Keyur Parekh’s has documented 19 price targets and ratings displayed on 5 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on GSK, GlaxoSmithKline PLC ADR at 24-Feb-2023.

Wall Street Analyst Keyur Parekh

Analyst best performing recommendations are on NVO (NOVO NORDISK A/S).
The best stock recommendation documented was for NVS (NOVARTIS AG ADR) at 11/19/2018. The price target of $77.42 was fulfilled within 211 days with a profit of $12.9 (19.99%) receiving and performance score of 0.95.

Average potential price target upside

AZN AstraZeneca PLC ADR NVS Novartis AG ADR SNY Sanofi ADR NVO Novo Nordisk A/S GSK GlaxoSmithKline PLC ADR

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

80

$12.3 (18.17%)

83

2 months 1 days ago

0/3 (0%)

$19.52 (32.28%)

Buy

85

$17.3 (25.55%)

2 months 21 days ago

0/11 (0%)

$19.26 (29.30%)

Hold

70

$2.3 (3.40%)

3 months 10 days ago

4/5 (80%)

$2.71 (4.03%)

253

Buy

142.74

9 months 1 days ago

0/6 (0%)

$75.62 (112.66%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Keyur Parekh?

On 2018

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?